ID   AD3 [Human myeloma]
AC   CVCL_M504
DR   Wikidata; Q54608719
RX   DOI=10.1007/0-306-46877-8_4;
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=1697013;
RX   PubMed=10936422;
CC   Population: Japanese.
CC   Characteristics: Produces IgA kappa.
CC   Doubling time: 16 hours (PubMed=1697013).
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C3242; Plasma cell myeloma
DI   ORDO; Orphanet_29073; Multiple myeloma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_M505 ! FR4
SX   Male
AG   69Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 10-09-24; Version: 15
//
RX   DOI=10.1007/0-306-46877-8_4;
RA   Jernberg-Wiklund H., Nilsson K.;
RT   "Multiple myeloma cell lines.";
RL   (In book chapter) Human cell culture. Vol. 3. Cancer cell lines part 3; Masters J.R.W., Palsson B.O. (eds.); pp.81-155; Kluwer Academic Publishers; New York; USA (2000).
//
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RA   Drexler H.G.;
RT   "The leukemia-lymphoma cell line factsbook.";
RL   (In book) ISBN 9780122219702; pp.1-733; Academic Press; London; United Kingdom (2001).
//
RX   PubMed=1697013;
RA   Tagawa S., Doi S., Taniwaki M., Abe T., Kanayama Y., Nojima J.,
RA   Matsubara K.-i., Kitani T.;
RT   "Amylase-producing plasmacytoma cell lines, AD3 and FR4, with
RT   der(14)t(8;14) and dic(8)t(1;8) established from ascites.";
RL   Leukemia 4:600-605(1990).
//
RX   PubMed=10936422; DOI=10.1016/S0145-2126(99)00195-2;
RA   Drexler H.G., Matsuo Y.;
RT   "Malignant hematopoietic cell lines: in vitro models for the study of
RT   multiple myeloma and plasma cell leukemia.";
RL   Leuk. Res. 24:681-703(2000).
//